Evidence map›Paper›PMID 31477167›Full record

ArticleGenome biology2019

Contrasting patterns of longitudinal population dynamics and antimicrobial resistance mechanisms in two priority bacterial pathogens over 7 years in a single center.

Matthew J Ellington, Eva Heinz, Alexander M Wailan, Matthew J Dorman, Marcus de Goffau, Amy K Cain, Sonal P Henson, Nicholas Gleadall, Christine J Boinett, Gordon Dougan and 6 more

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Pangenomic and biochemical analyses ofFrontiers in microbiology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Emergence of Neonatal Sepsis Caused by MCR-9- and NDM-1-Co-ProducingFrontiers in cellular and infection microbiology · 2022
    Article
  9. Ten Years of Population-Level Genomic Escherichia coli and Klebsiella pneumoniae Serotype Surveillance Informs Vaccine Development for Invasive Infections.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Population genomics of Klebsiella pneumoniae.Nature reviews. Microbiology · 2020
    Review
  15. Article
  16. Microorganisms · 2020
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Matthew J EllingtonPublic Health England, National Infection Service, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QW, UK. matthew.ellington@phe.gov.uk.ORCID 0000-0002-0656-3360
Eva HeinzWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Alexander M WailanWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Matthew J DormanWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Marcus de GoffauWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Amy K CainWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Sonal P HensonKEMRI-Wellcome Trust Research Programme, CGMRC, Kilifi, Kenya.
Nicholas GleadallPublic Health England, National Infection Service, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QW, UK.
Christine J BoinettWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Gordon DouganWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Nicholas M BrownPublic Health England, National Infection Service, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QW, UK.
Neil WoodfordAntimicrobial Resistance and Healthcare Associated Infections (AMRHAI) Reference Unit, National Infection Service, Public Health England, 61 Colindale Avenue, London, NW9 5EQ, UK.
Julian ParkhillWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
M Estée TörökPublic Health England, National Infection Service, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QW, UK.
Sharon J PeacockPublic Health England, National Infection Service, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QW, UK.
Nicholas R ThomsonWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1SA, UK.
Wellcome Sanger Institute · GBPublic Health England · GBUniversity of Cambridge · GBUniversity of London · GBCambridge University Hospitals NHS Foundation Trust · GBKenya Medical Research Institute · KELiverpool School of Tropical Medicine · GB

Funding

Department of HealthHealth Protection Agency 108077Medical Research Council G1000803Medical Research Council MR/N029399/1Wellcome Trust 098051
6 · The paper itself

Abstract

backgroundTwo of the most important pathogens contributing to the global rise in antimicrobial resistance (AMR) are Klebsiella pneumoniae and Enterobacter cloacae. Despite this, most of our knowledge about the changing patterns of disease caused by these two pathogens is based on studies with limited timeframes that provide few insights into their population dynamics or the dynamics in AMR elements that they can carry.

resultsWe investigate the population dynamics of two priority AMR pathogens over 7 years between 2007 and 2012 in a major UK hospital, spanning changes made to UK national antimicrobial prescribing policy in 2007. Between 2006 and 2012, K. pneumoniae showed epidemiological cycles of multi-drug-resistant (MDR) lineages being replaced approximately every 2 years. This contrasted E. cloacae where there was no temporally changing pattern, but a continuous presence of the mixed population.

conclusionsThe differing patterns of clonal replacement and acquisition of mobile elements shows that the flux in the K. pneumoniae population was linked to the introduction of globally recognized MDR clones carrying drug resistance markers on mobile elements. However, E. cloacae carries a chromosomally encoded ampC conferring resistance to front-line treatments and shows that MDR plasmid acquisition in E. cloacae was not indicative of success in the hospital. This led to markedly different dynamics in the AMR populations of these two pathogens and shows that the mechanism of the resistance and its location in the genome or mobile elements is crucial to predict population dynamics of opportunistic pathogens in clinical settings.

Indexed as

Anti-Bacterial AgentsConserved SequenceDrug Resistance, BacterialEnterobacter cloacaeGenetic VariationGenome, BacterialKlebsiella pneumoniaePopulation DynamicsSequence Analysis, DNAAnti-Bacterial AgentsIntrinsic resistancePlasmid diversityPopulation dynamicsResistance mechanisms

Identifiers

PMID31477167
PMCPMC6717969
OpenAlexW2970781858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.